Not applicableStudy completedNCT04148157What this trial is testingQuality of Life in IPF - Patient and Physician PerceptionsWho this might be right forIdiopathic Pulmonary Fibrosis University of Washington 100
Testing effectiveness (Phase 2)Study completedNCT03312400What this trial is testingLow-Dose Danazol for the Treatment of Telomere Related DiseasesWho this might be right forTelomere Disease National Heart, Lung, and Blood Institute (NHLBI) 18
Not applicableStudy completedNCT03770845What this trial is testingNutritional Assessment in Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis San Gerardo Hospital 100
Large-scale testing (Phase 3)Ended earlyNCT04552899What this trial is testingEvaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis Hoffmann-La Roche 665
Testing effectiveness (Phase 2)Ended earlyNCT03562416What this trial is testingContinuation of Nintedanib After Single Lung Transplantation in IPF SubjectsWho this might be right forIdiopathic Pulmonary FibrosisLung Transplant; Complications Temple University 1
Very early researchStudy completedNCT03928847What this trial is testingFibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis.Who this might be right forIdiopathic Pulmonary Fibrosis Hal Chapman 35
Not applicableLooking for participantsNCT07723872What this trial is testingFinger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung DiseaseWho this might be right forInterstitial Lung Disease (ILD)Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis+2 more Hospital de Granollers 100
Not applicableUnknownNCT03840928What this trial is testingPatientSpot Formerly Known as ArthritisPowerWho this might be right forRheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more Global Healthy Living Foundation 40,000
Not applicableStudy completedNCT01121367What this trial is testingStudy on Phenotypic Characterization of Combined Pulmonary Fibrosis and EmphysemaWho this might be right forPulmonary FibrosisEmphysema Beijing Chao Yang Hospital 82
Not applicableStudy completedNCT03958071What this trial is testingA Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are TakingWho this might be right forIdiopathic Pulmonary Fibrosis Boehringer Ingelheim 13,264
Not applicableStudy completedNCT03981406What this trial is testingPalliative Care and Quality of Life in Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary FibrosisDepressionAnxiety+3 more University of Minnesota 22
Not applicableStudy completedNCT04564664What this trial is testingHigh-flow Oxygen Therapy During Exercise in Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis Parc de Salut Mar 10
Early research (Phase 1)Study completedNCT06135363What this trial is testingSafety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy SubjectsWho this might be right forIdiopathic Pulmonary Fibrosis Guangzhou JOYO Pharma Co., Ltd 45
Testing effectiveness (Phase 2)Ended earlyNCT03287414What this trial is testingStudy of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis Novartis Pharmaceuticals 30
Testing effectiveness (Phase 2)UnknownNCT05424887What this trial is testingEvaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis Shanghai Ark Biopharmaceutical Co., Ltd. 105
Large-scale testing (Phase 3)Ended earlyNCT00879229What this trial is testingARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary FibrosisPulmonary Hypertension Gilead Sciences 40
Testing effectiveness (Phase 2)WithdrawnNCT00878761What this trial is testingStudy of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA)Who this might be right forChronic Allograft Dysfunction Stromedix, Inc. 48
Post-approval studies (Phase 4)WithdrawnNCT00625469What this trial is testingPulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With BosentanWho this might be right forPulmonary Arterial HypertensionIdiopathic Pulmonary Fibrosis Rajan Saggar
Large-scale testing (Phase 3)Ended earlyNCT03267108What this trial is testingAssess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary HypertensionWho this might be right forPulmonary FibrosisPulmonary Hypertension Bellerophon Pulse Technologies 145
Large-scale testing (Phase 3)Study completedNCT02597933What this trial is testingA Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung FibrosisWho this might be right forScleroderma, Systemic Boehringer Ingelheim 580